Cargando…
Soluble VEGF receptor 1 (sFLT1) induces non-apoptotic death in ovarian and colorectal cancer cells
Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1/sFLT1) is an angiogenesis inhibitor that competes with angiogenic factors such as VEGF and Placental Growth Factor (PlGF). Imbalances of VEGF and sFLT1 levels can cause pathological conditions such as tumour growth or preeclampsia. We ob...
Autores principales: | Miyake, Tatsuya, Kumasawa, Keiichi, Sato, Noriko, Takiuchi, Tsuyoshi, Nakamura, Hitomi, Kimura, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840331/ https://www.ncbi.nlm.nih.gov/pubmed/27103202 http://dx.doi.org/10.1038/srep24853 |
Ejemplares similares
-
The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice
por: Zhao, Guangxian, et al.
Publicado: (2017) -
The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy
por: Zhai, Yaling, et al.
Publicado: (2020) -
Elevated Soluble VEGF Receptor sFlt-1 Correlates with Endothelial Injury in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2014) -
VEGF and sFLT-1 in serum of PIH patients and effects on the foetus
por: Tang, Yanhong, et al.
Publicado: (2019) -
The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia
por: Miyatake, Risa, et al.
Publicado: (2023)